431 |
CARESS-in-AMI |
Carlo Di Mario |
Sep. 26. 08 |
430 |
Treatment Modalities for Diagnosing and Treatment of Vulnerable Plaque |
Ron Waksman |
Sep. 26. 08 |
429 |
Reconciling Angiographic and Clinical Results After Stent Treatment: A Critical Appraisal and Recommendations for Clinical Assessments of Future Stents |
Jeffrey J. Popma |
Sep. 26. 08 |
428 |
Drug Eluting Stents: How Can We Know If "Newer" Is Actually "Better"? |
Mitchell W. Krucoff |
Sep. 26. 08 |
427 |
The Complex Relation Between Vulnerability and Ischemia |
Nico Pijls |
Sep. 26. 08 |
426 |
Current Management of ACS |
Robbert De Winter |
Sep. 26. 08 |
425 |
Does PCI Reduce Mortality? A Meta-Analysis of 17 Studies Comparing PCI (Bare Metal and Drug-Eluting Stents) vs. Medical Therapy |
Adnan Kastrati |
Sep. 26. 08 |
424 |
[Debate] Which one Is the Best Choice in Left Main Revascularization?: : CABG Is the Best Choice. |
David Paul Taggart |
Sep. 26. 08 |
423 |
[Debate] Which one Is the Best Choice in Left Main Revascularization?: : PCI Is the Best Choice. |
David R. Holmes |
Sep. 26. 08 |
422 |
DES Controversies: To Leave Diseased Arteries Alone |
Spencer B. King III |
Sep. 19. 08 |